Assessment of risk of bias among pediatric randomized controlled trials

Pediatrics

Volumn 126, Issue 2, 2010, Pages 298-305

  Crocetti, Michael T ^a   Amin, Diane D ^a   Scherer, Roberta ^b  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cochrane collaboration; Controlled trial; High impact journal; Randomized; Risk of bias

Indexed keywords

VACCINE;

ARTICLE; BEHAVIOR; CHILD; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH EDUCATION; HIGH RISK PATIENT; HUMAN; INTERVENTION STUDY; MEDICAL LITERATURE; MULTICENTER STUDY; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PEDIATRICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGISTRATION; RESOURCE ALLOCATION; RISK ASSESSMENT;

BIAS (EPIDEMIOLOGY); CHILD; HUMANS; INFANT; MULTICENTER STUDIES AS TOPIC; PUBLICATION BIAS; PUBLISHING; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 77955496499     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-3121     Document Type: Article

References (14)

1. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 [updated September 2008]. Baltimore, MD: Cochrane Collaboration; 2008. Available at: www.cochrane-handbook.org. Accessed November 10, 2008
2. Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials. 1995;16(1): 62-73
3. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA. 1999;282(11): 1054-1060 (Pubitemid 29436453)
4. Hartling L, Ospina M, Liang Y, et al. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ. 2009;339:b4012
5. Garfield E. The history and meaning of the journal impact factor. JAMA. 2006;295(1): 90-93
6. ISI Web of Knowledge. Journal Citation Reports. Available at: http://admin-apps.isiknowledge.com/JCR/JCR?SID=2DaK7OpgGi51pLo8CaG. Accessed June 7, 2010
7. Cohen E, Uleryk E, Jasuja M, Parkin PC. An absence of pediatric randomized controlled trials in general medical journals. J Clin Epidemiol. 2007;60(2):118-123
8. Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA. 2003;290(7):921-928 (Pubitemid 37430464)
9. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systemic review. BMJ. 2003;326(7400): 1167-1176 (Pubitemid 36649048)
10. Pildal J, Hróbjartsson A, Jørgensen KJ, Hilden J, Altman DG, Gøtzsche PC. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol. 2007;36(4): 847-857
11. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273(5):408-412
12. Wood AM, White IR, Thompson SG. Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals. Clin Trials. 2004;1(4):368-376
13. DeAngelis CD, Drazen JM, Frizelle FA, et al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. JAMA. 2005; 293(23):2927-2929
14. US National Institutes of Health. About ClinicalTrials.gov. Available at: www. clinicaltrials.gov/ct2/home. Accessed April 1, 2009